Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) Overview Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a rare inherited neurodegenerative disorder that affects balance, muscle control, and peripheral nerves ARSACS is a neuromuscular condition characterized by the progressive degeneration of the cerebellum and spinal cord. Symptoms ARSACS is defined by three main clinical features: Cerebellar ataxia: Balance and coordination problems, leading to a clumsy or wide-based gait, frequent falls, and poor coordination in the arms and hands. Spasticity: Abnormal, progressive muscle stiffness and tensing, which usually affects the legs more severely over time. Sensorimotor polyneuropathy: Reduced sensation, weakness, and numbness in the arms and legs due to damage to the peripheral nerves Musculoskeletal changes: Distal muscle wasting (amyotrophy) in the hands and feet, foot deformities such as high arches (pes cavus), and spinal curvature (scoliosis...
Spastic Paraplegia Type 49 Overview The first symptom of spastic paraplegia type 49 is typically weak muscle tone (hypotonia) that starts in infancy. The spasticity and paraplegia gradually worsen over time during childhood, leading to difficulty walking and frequent falls. Affected individuals may also have intellectual disability and distinctive physical features, including short stature, chubbiness, and smaller head size (microcephaly). There is currently no specific treatment to prevent or reverse progressive disability in patients with spastic paraplegia. This condition is caused by pathogenic (disease-causing) variants in the TECPR2 gene. Additionally, spastic paraplegia type 49 exhibits autosomal recessive inheritance, meaning both parents must be carriers to have a 25% chance of having a child with the condition. The risk of being a carrier is based on a person’s ancestry or ethnic background. For example, individuals of Sephardic Jewish- Bukharian descent have a carrier freque...